Literature DB >> 12537517

Assessment of Markov-dependent stochastic models for drug administration compliance.

Diane Wong1, Reshma Modi, Murali Ramanathan.   

Abstract

OBJECTIVE: There are few analytical results that describe patient compliance with drug administration regimens. The purpose of this paper is to develop and assess stochastic approaches for mathematical modelling of patient compliance with administration regimens.
METHODS: Two stochastic models based on Markov-dependent random variables and on the Ising model were assessed for their ability to describe the variable nature of drug compliance.
RESULTS: Both models use only experimentally accessible data, and their predictions were tested against published clinical compliance data obtained from electronic monitoring devices. The models satisfactorily fitted administration interval distribution data from several patients treated with diltiazem, a calcium channel antagonist, or zidovudine, an antiretroviral agent. The Ising model provides additional analytical expressions for the distribution of success runs and 'drug holidays' in administration regimens. These distribution predictions were tested with success run data for diltiazem and drug holiday data for two nonsteroidal anti-inflammatory drugs, piroxicam and tenoxicam.
CONCLUSIONS: Stochastic models can provide useful insights into drug compliance, and can be used to identify the administration patterns that are more likely to occur during drug self-administration in populations.

Entities:  

Mesh:

Year:  2003        PMID: 12537517     DOI: 10.2165/00003088-200342020-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  11 in total

1.  Impact of dosage frequency on patient compliance.

Authors:  A H Paes; A Bakker; C J Soe-Agnie
Journal:  Diabetes Care       Date:  1997-10       Impact factor: 19.112

Review 2.  Revisiting the effect compartment through timing errors in drug administration.

Authors:  P Nony; M Cucherat; J P Boissel
Journal:  Trends Pharmacol Sci       Date:  1998-02       Impact factor: 14.819

3.  Facilitated analysis of data on drug regimen compliance.

Authors:  E de Klerk; S van der Linden; D van der Heijde; J Urquhart
Journal:  Stat Med       Date:  1997-07-30       Impact factor: 2.373

4.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

Review 5.  Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens.

Authors:  J Urquhart
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

Review 6.  Intention-to-treat analysis and the goals of clinical trials.

Authors:  L B Sheiner; D B Rubin
Journal:  Clin Pharmacol Ther       Date:  1995-01       Impact factor: 6.875

Review 7.  A pharmacokinetic perspective on medicament noncompliance.

Authors:  G Levy
Journal:  Clin Pharmacol Ther       Date:  1993-09       Impact factor: 6.875

8.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

9.  Prediction of diltiazem plasma concentration curves from limited measurements using compliance data.

Authors:  A Rubio; C Cox; M Weintraub
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

10.  A Markov mixed effect regression model for drug compliance.

Authors:  P Girard; T F Blaschke; H Kastrissios; L B Sheiner
Journal:  Stat Med       Date:  1998-10-30       Impact factor: 2.373

View more
  9 in total

1.  Bayesian population modeling of drug dosing adherence.

Authors:  Kelly Fellows; Colin J Stoneking; Murali Ramanathan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-29       Impact factor: 2.745

2.  A probabilistic approach for the evaluation of pharmacological effect induced by patient irregular drug intake.

Authors:  Jun Li; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-06-25       Impact factor: 2.745

3.  Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens.

Authors:  Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

4.  Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients.

Authors:  N M Ferguson; C A Donnelly; J Hooper; A C Ghani; C Fraser; L M Bartley; R A Rode; P Vernazza; D Lapins; S L Mayer; R M Anderson
Journal:  J R Soc Interface       Date:  2005-09-22       Impact factor: 4.118

5.  A hybrid Markov chain-von Mises density model for the drug-dosing interval and drug holiday distributions.

Authors:  Kelly Fellows; Vivian Rodriguez-Cruz; Jenna Covelli; Alyssa Droopad; Sheril Alexander; Murali Ramanathan
Journal:  AAPS J       Date:  2015-01-22       Impact factor: 4.009

Review 6.  Facilitation of drug evaluation in children by population methods and modelling.

Authors:  Michel Tod; Vincent Jullien; Gérard Pons
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Clustering based on adherence data.

Authors:  Sylvia Kiwuwa-Muyingo; Hannu Oja; Sarah A Walker; Pauliina Ilmonen; Jonathan Levin; Jim Todd
Journal:  Epidemiol Perspect Innov       Date:  2011-03-08

8.  A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration.

Authors:  S Sanche; N Sheehan; T Mesplède; M A Wainberg; J Li; F Nekka
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-05-27

9.  Quantification of the Forgiveness of Drugs to Imperfect Adherence.

Authors:  P Assawasuwannakit; R Braund; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.